Literature DB >> 17534694

Non-invasive low frequency vibration as a potential emergency adjunctive treatment for heart attack and stroke. An in vitro flow model.

Fesseha G Yohannes1, Andrew K Hoffmann.   

Abstract

BACKGROUND: Myocardial infarction and stroke (arterial thrombosis) comprise the leading killers and sources of disability in the developed world, and incomplete thrombolysis along with high bleeding rates (plus late presentations to cathlabs) have prompted an intensive search for alternative or adjunctive emergency therapies. Transcutaneous ultrasound has been studied in remediation of thrombosis, but has been problematic due to poor penetration, risk of arterial damage, plus the apparent need for a highly skilled approach. Surprisingly there has been no reported studies on the much simpler application of transcutaneous low frequency vibration (well known for its superior penetration and flow enhancing characteristics) to assist arterial thrombolysis. The aim of our experiment therefore was to test the hypothesis whether vibration (i.e. approximately 100 Hz, 0.5 mm), when applied across an attenuating barrier, would assist recanulization of a thrombosed flow system held at arterial like pressure.
METHODS: A teddy bear with a 2 cm slab of New York Steak placed upon its chest surface was used as a test subject with an in-dwelling catheter (approximately 4.0 mm lumen) cannulated through the bear's thorax. In a series of test runs (n=30), a 2 h old (or older) blood clot was injected into the catheter such as to occlude it at a stenosis site (approximately 90% luminal narrowing) created by a clamp placed along the catheter within the teddy's chest region. A pressurized heparinized IV system was in all cases connected to the catheter such as to yield an "arterial like" lumen pressure proximal the obstruction. For each test run, after a twenty minute observation period to confirm stability of the occlusion, test groups where randomized to receive vibration to the slab of steak upon the teddy's "chest wall" (generally overlying the site of the thrombotic obstruction), or no vibration for an evaluation period of up to 45 min.
RESULTS: Catheter reflow occurred rapidly (median reflow-time 90 s) in the vibration groups within the evaluation period (i.e. 15/17), while the system remained otherwise blocked in the control groups receiving no vibration (i.e. 0/13). The difference in flow system patency rate for the vibration groups vs. the control groups was statistically significant (P=0.0000009).
CONCLUSIONS: The frequent and generally rapid re-establishment of flow in vibration groups compared to the complete absence of reflow in control groups confirms the hypothesis that vibration applied across a physical barrier assists clearance of a blood clot in a stenosed flow system under systemic levels of pressure. We studied the incidence of clearance of a blood clot within a stenosed, heparanized catheter system held at arterial like pressure that was treated with externally delivered low frequency vibration (applied proximate the thrombotic occlusion across an attenuating medium--a 2 cm thick slab of New York Steak--at approximately 100 Hz, 0.5 mm), versus no vibration. Reflow in test runs incorporating vibration occurred faster, and resulted in significantly greater recanulization rates in the catheter system versus test runs without vibration (P=0.0000009). Non-invasive vibration holds potential as an adjunct to pharmacologic therapy in treatment of acute arterial thrombosis. Further study of this technique appears warranted in live animal models.

Entities:  

Mesh:

Year:  2007        PMID: 17534694     DOI: 10.1007/s11239-007-0054-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  46 in total

Review 1.  Therapeutic ultrasound: its application in drug delivery.

Authors:  Ka-yun Ng; Yang Liu
Journal:  Med Res Rev       Date:  2002-03       Impact factor: 12.944

2.  Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.

Authors:  Carlos A Molina; Marc Ribo; Marta Rubiera; Joan Montaner; Esteban Santamarina; Raquel Delgado-Mederos; Juan F Arenillas; Rafael Huertas; Francisco Purroy; Pilar Delgado; José Alvarez-Sabín
Journal:  Stroke       Date:  2005-12-22       Impact factor: 7.914

3.  Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model.

Authors:  Stefan Pfaffenberger; Branka Devcic-Kuhar; Christian Kollmann; Stefan P Kastl; Christoph Kaun; Walter S Speidl; Thomas W Weiss; Svitlana Demyanets; Robert Ullrich; Heinz Sochor; Christian Wöber; Josef Zeitlhofer; Kurt Huber; Martin Gröschl; Ewald Benes; Gerald Maurer; Johann Wojta; Michael Gottsauner-Wolf
Journal:  Stroke       Date:  2004-12-09       Impact factor: 7.914

4.  Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy.

Authors:  D Hackett; G Davies; S Chierchia; A Maseri
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

5.  Measurement of instantaneous viscoelastic properties by impedance-frequency curve of the ventricle.

Authors:  Y Koiwa; R Hashiguchi; T Ohyama; S Isoyama; S Satoh; H Suzuki; T Takishima
Journal:  Am J Physiol       Date:  1986-04

6.  Ultrasound enhancement of rabbit femoral artery thrombolysis.

Authors:  P N Riggs; C W Francis; S R Bartos; D P Penney
Journal:  Cardiovasc Surg       Date:  1997-04

7.  Time is brain--quantified.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

Review 9.  Clinical management of the patient with an acute myocardial infarction.

Authors:  M A Woo
Journal:  Nurs Clin North Am       Date:  1992-03       Impact factor: 1.208

10.  Does external ultrasound accelerate thrombolysis? Results from a rabbit model.

Authors:  R Kornowski; R S Meltzer; A Chernine; Z Vered; A Battler
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

View more
  5 in total

1.  A study to determine chest wall vibratory attachment interface locations for a low frequency sonic vibrator in treatment of acute coronary thrombosis.

Authors:  Andrew Kenneth Hoffmann; Harjit Gill
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

2.  Low-Frequency Vibrations Enhance Thrombolytic Therapy and Improve Stroke Outcomes.

Authors:  Nirav Dhanesha; Thomas Schnell; Salam Rahmatalla; Jonathan DeShaw; Daniel Thedens; Bradley M Parker; M Bridget Zimmerman; Andrew A Pieper; Anil K Chauhan; Enrique C Leira
Journal:  Stroke       Date:  2020-05-13       Impact factor: 7.914

3.  Diastolic timed Vibro-Percussion at 50 Hz delivered across a chest wall sized meat barrier enhances clot dissolution and remotely administered Streptokinase effectiveness in an in-vitro model of acute coronary thrombosis.

Authors:  Andrew Hoffmann; Harjit Gill
Journal:  Thromb J       Date:  2012-11-12

4.  Low frequency mechanical actuation accelerates reperfusion in-vitro.

Authors:  Marcin Marzencki; Behrad Kajbafzadeh; Farzad Khosrow-Khavar; Kouhyar Tavakolian; Maxim Soleimani-Nouri; Jaap Hamburger; Bozena Kaminska; Carlo Menon
Journal:  Biomed Eng Online       Date:  2013-11-21       Impact factor: 2.819

5.  Thrombus Imaging Using 3D Printed Middle Cerebral Artery Model and Preclinical Imaging Techniques: Application to Thrombus Targeting and Thrombolytic Studies.

Authors:  Andrea Vítečková Wünschová; Adam Novobilský; Jana Hložková; Peter Scheer; Hana Petroková; Radovan Jiřík; Pavel Kulich; Eliška Bartheldyová; František Hubatka; Vladimír Jonas; Robert Mikulík; Petr Malý; Jaroslav Turánek; Josef Mašek
Journal:  Pharmaceutics       Date:  2020-12-12       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.